Abstract Peripheral T-cell lymphomas not otherwise specified are generally considered aggressive non-Hodgkin lymphomas, because of poor natural outcome and response to therapy. They show a complex karyotype without any specific genetic hallmark. We report a case of peripheral T-cell lymphoma not otherwise specified with heterogeneous nuclear Cyclin D1 immunohistochemical overexpression, due to gene copy gain, a phenomenon similar to that observed in Mantle Cell Lymphoma characterized by t(11;14)(q13;q32). In this case report we underline the diagnostic pitfall rapresented by Cyclin D1 immunoistochemical overexpression in a T-cell lymphoma. Several pitfalls could lead to misinterpretation of diagnosis, therefore, we underlined the need to in...
AbstractIntroductionPeripheral T-cell lymphomas represent a rare, heterogeneous group of nodal and e...
At the molecular level mantle cell lymphoma (MCL) is characterized by a specific translocation t(11;...
The translocation (11;14)(q13;q32) and its molecular counterpart the BCL-1 rearrangement are feature...
Increased expression of cyclin D1 is notoriously associated with mantle cell lymphoma because of tra...
Peripheral T-cell lymphomas (PTCLs) are heterogeneous and uncommon malignancies characterized by a u...
Disease Peripheral T-cell lymphomas not otherwise specified (PTCL-NOS) include a heterogeneous grou...
Cyclin D1 overexpression is believed to be essential in the pathogenesis of mantle cell lymphoma (MC...
lymphoma with strong expression of cyclin D1, but without evidence of CCND1 translocation or amplifi...
Cyclin D1+ mantle cell lymphoma (MCL) is molecularly characterized by the t(11;14)(q13;q32) or rear...
The cell cycle regulatory protein cyclin D1 is essential for mia, low-grade lymphomas of mucosa-asso...
Peripheral T-cell lymphomas (PTCLs) encompass a group of rare and usually clinically aggressive dise...
Peripheral T-cell lymphomas (PTCL) are rare neoplasms that in most instances respond poorly to conve...
Nodal peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) with cytotoxic phenotype is ov...
Prolymphocytic transformation is a concept usually applied in the context of chronic lymphocytic leu...
Peripheral T-cell lymphomas (PTCLs) represent a heterogeneous group of more than 20 neoplastic entit...
AbstractIntroductionPeripheral T-cell lymphomas represent a rare, heterogeneous group of nodal and e...
At the molecular level mantle cell lymphoma (MCL) is characterized by a specific translocation t(11;...
The translocation (11;14)(q13;q32) and its molecular counterpart the BCL-1 rearrangement are feature...
Increased expression of cyclin D1 is notoriously associated with mantle cell lymphoma because of tra...
Peripheral T-cell lymphomas (PTCLs) are heterogeneous and uncommon malignancies characterized by a u...
Disease Peripheral T-cell lymphomas not otherwise specified (PTCL-NOS) include a heterogeneous grou...
Cyclin D1 overexpression is believed to be essential in the pathogenesis of mantle cell lymphoma (MC...
lymphoma with strong expression of cyclin D1, but without evidence of CCND1 translocation or amplifi...
Cyclin D1+ mantle cell lymphoma (MCL) is molecularly characterized by the t(11;14)(q13;q32) or rear...
The cell cycle regulatory protein cyclin D1 is essential for mia, low-grade lymphomas of mucosa-asso...
Peripheral T-cell lymphomas (PTCLs) encompass a group of rare and usually clinically aggressive dise...
Peripheral T-cell lymphomas (PTCL) are rare neoplasms that in most instances respond poorly to conve...
Nodal peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) with cytotoxic phenotype is ov...
Prolymphocytic transformation is a concept usually applied in the context of chronic lymphocytic leu...
Peripheral T-cell lymphomas (PTCLs) represent a heterogeneous group of more than 20 neoplastic entit...
AbstractIntroductionPeripheral T-cell lymphomas represent a rare, heterogeneous group of nodal and e...
At the molecular level mantle cell lymphoma (MCL) is characterized by a specific translocation t(11;...
The translocation (11;14)(q13;q32) and its molecular counterpart the BCL-1 rearrangement are feature...